Recent studies indicated that p57Kip2 was frequently downregulated in multiple types of human cancers such as breast cancer, hepatocellular carcinoma, colorectal cancer, and ovarian cancer32,33. This evidence concerns the gene CDKN1C and breast carcinoma.